CGP12177 [Ligand Id: 532] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL420746
  • β1-adrenoceptor/Beta-1 adrenergic receptor in Human [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
There should be some charts here, you may need to enable JavaScript!
  • β2-adrenoceptor/Beta-2 adrenergic receptor in Human [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
There should be some charts here, you may need to enable JavaScript!
  • β3-adrenoceptor/Beta-3 adrenergic receptor in Human [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
  • β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
β1-adrenoceptor/Beta-1 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL213] [GtoPdb: 28] [UniProtKB: P08588]
GtoPdb - - 9.4 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 525-32 [PMID:15060759];
Eur J Pharmacol (1999) 367: 431-5 [PMID:10079020];
Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2016) 4: e00250 [PMID:27588207];
PLoS One (2013) 8: e77582 [PMID:24250787];
Pharmacol Res Perspect (2025) 13: e70154 [PMID:40887869];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653];
ACS Pharmacol Transl Sci (2020) 3: 737-748 [PMID:32832874]
GtoPdb - - 9.4 pKi - - - Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 525-32 [PMID:15060759];
Eur J Pharmacol (1999) 367: 431-5 [PMID:10079020];
Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Pharmacol Res Perspect (2016) 4: e00250 [PMID:27588207];
PLoS One (2013) 8: e77582 [PMID:24250787];
Pharmacol Res Perspect (2025) 13: e70154 [PMID:40887869];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653];
ACS Pharmacol Transl Sci (2020) 3: 737-748 [PMID:32832874]
ChEMBL Partial agonist activity at human beta1 adrenoceptor expressed in CHOK1 cells assessed as induction of [3H]cAMP accumulation after 5 hrs F 7.91 pEC50 12.3 nM EC50 J Med Chem (2013) 56: 3852-3865 [PMID:23614528]
GtoPdb - - 9.1 pEC50 - - - J Pharmacol Exp Ther (2005) 313: 1163-71 [PMID:15716385];
Mol Pharmacol (2003) 63: 1312-21 [PMID:12761341];
Mol Pharmacol (2014) 85: 811-29 [PMID:24608857];
PLoS One (2013) 8: e77582 [PMID:24250787];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2008) 74: 1246-60 [PMID:18687809];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653];
Mol Pharmacol (2019) 96: 851-861 [PMID:31624135]
GtoPdb - - 10 pA2 - - - Mol Pharmacol (2003) 63: 1312-21 [PMID:12761341];
Mol Pharmacol (2014) 85: 811-29 [PMID:24608857];
PLoS One (2013) 8: e77582 [PMID:24250787];
Mol Pharmacol (2008) 74: 1246-60 [PMID:18687809];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
β2-adrenoceptor/Beta-2 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL210] [GtoPdb: 29] [UniProtKB: P07550]
ChEMBL Displacement of [3H]DHA from inactive/G protein-uncoupled human beta2-AR expressed in CHO cell membranes assessed as intrinsic Kd by liquid scintillation counting B 7.72 pKd 19 nM Kd J Med Chem (2016) 59: 5780-5789 [PMID:27239696]
ChEMBL Displacement of [3H]DHA from inactive/G protein-uncoupled human beta2-AR expressed in CHO cell membranes by liquid scintillation counting B 9.7 pKd 0.2 nM Kd J Med Chem (2016) 59: 5780-5789 [PMID:27239696]
GtoPdb - - 9.8 pKi - - - Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
Pharmacol Res Perspect (2025) 13: e70154 [PMID:40887869];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653];
Mol Pharmacol (2019) 96: 851-861 [PMID:31624135];
J Pharmacol Exp Ther (2013) 344: 218-30 [PMID:23131596]
GtoPdb - - 9.8 pKi - - - Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Br J Pharmacol (2002) 137: 400-8 [PMID:12237261];
Pharmacol Res Perspect (2025) 13: e70154 [PMID:40887869];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653]
GtoPdb - - 9.7 pEC50 - - - Br J Pharmacol (2002) 137: 400-8 [PMID:12237261];
Mol Pharmacol (2014) 85: 811-29 [PMID:24608857];
Pharmacol Res Perspect (2026) 14: e70214 [PMID:41485077];
Mol Pharmacol (2025) 107: 100081 [PMID:41289653];
Mol Pharmacol (2019) 96: 851-861 [PMID:31624135];
Mol Pharmacol (2004) 65: 986-98 [PMID:15044629]
GtoPdb - - 10 pA2 - - - Br J Pharmacol (2002) 137: 400-8 [PMID:12237261];
Mol Pharmacol (2014) 85: 811-29 [PMID:24608857]
β3-adrenoceptor/Beta-3 adrenergic receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL246] [GtoPdb: 30] [UniProtKB: P13945]
GtoPdb - - 7.1 pKi - - - Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421];
Br J Pharmacol (1994) 112: 911-9 [PMID:7921620];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
Fundam Clin Pharmacol (1995) 9: 211-8 [PMID:7557816]
GtoPdb - - 7.3 pKi - - - Eur J Pharmacol (1999) 367: 431-5 [PMID:10079020];
Br J Pharmacol (2005) 144: 317-22 [PMID:15655528];
Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421];
Br J Pharmacol (1994) 112: 911-9 [PMID:7921620];
Naunyn Schmiedebergs Arch Pharmacol (2004) 369: 151-9 [PMID:14730417];
Fundam Clin Pharmacol (1995) 9: 211-8 [PMID:7557816]
ChEMBL Agonist efficacy for human Beta-3 adrenergic receptor expressed in chinese hamster ovary cells F 5.7 pEC50 2000 nM EC50 Bioorg Med Chem Lett (1997) 7: 219-224
GtoPdb - - 7 pEC50 - - - Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421];
Br J Pharmacol (1994) 112: 911-9 [PMID:7921620];
Br J Pharmacol (2010) 160: 1048-61 [PMID:20590599];
Mol Pharmacol (2005) 68: 1645-55 [PMID:16129733]
β3-adrenoceptor in Mouse [GtoPdb: 30] [UniProtKB: P25962]
GtoPdb - - 6.8 pKi - - - Annu Rev Pharmacol Toxicol (1997) 37: 421-50 [PMID:9131260];
Br J Pharmacol (1994) 112: 911-9 [PMID:7921620]
GtoPdb - - 6.8 pKi - - - Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421];
Br J Pharmacol (1994) 112: 911-9 [PMID:7921620]
GtoPdb - - 7.4 pEC50 - - - Eur J Pharmacol (1995) 291: 359-66 [PMID:8719421];
Br J Pharmacol (1994) 112: 911-9 [PMID:7921620]

ChEMBL data shown on this page come from version 37:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]